Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix.

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

Consumers are becoming more concerned about their health, with many prioritising weight loss. But what do they consider to be ...

For Immediate Release Chicago, IL – July 10, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog.

India's top endocrinologist, Dr Ambrish Mithal has come out with a very well timed and a much needed explainer on the new crop of weight loss drugs that have flooded the market. Entitled, "The Weight ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

The Therapeutic Goods Administration (TGA) has facilitated the seizure of millions of counterfeit and illegal therapeutic goods as part of INTERPOL's ...